Pinned
Reflecting on 2024: a category sweep of the Nobels, AI enabled clinical readouts, and the first trillion dollar pharma in sight.
We stand on the shoulders of giants. Looking to 2025: This is just the beginning. Make no small plans.
00:00
DIMENSION
416 posts
DIMENSION
@_DimensionCap
Dimension is a multistage, research oriented, investment firm partnering with companies across the frontiers of science and compute
- DIMENSION reposted
For large pharma companies serious about integrating ML throughout their organizations, I believe they'll need infrastructure like what @tamarindbio has created. With so many open and closed source solutions, a constantly changing model backdrop, pipelines that needWe’re proud to share that @tamarindbio has been selected to build, host, and operate the inference infrastructure layer for TuneLab2.0, the next evolution of the platform. @EliLillyandCo TuneLab is a first-of-its-kind, collaborative AI/ML drug discovery platform, bringing models
00:00 - DIMENSION reposted
every year @newlimit, we host friends at the lab & share our progress for 2026, we announced: - 2X increase in discovery rates with AI systems - new program for endothelial cells - 0 -> 1 medicines headed to the clinic - accelerating recovery from alcohol some highlights --
00:00 - DIMENSION reposted
Congrats to Deniz, Sherry and @tamarindbio team on the partnership with Lilly! Excited to announce that Lilly's TuneLab model initiative will be solely powered by Tamarind's platform. There are more high performance open and closed-source bio ML models now than ever. TamarindWe’re proud to share that @tamarindbio has been selected to build, host, and operate the inference infrastructure layer for TuneLab2.0, the next evolution of the platform. @EliLillyandCo TuneLab is a first-of-its-kind, collaborative AI/ML drug discovery platform, bringing models00:00 - DIMENSION reposted
Today we’re launching @chaidiscovery, led by @joshim5 & his polymathic world class cofounders. We’re also open sourcing Chai-1: a state of the art frontier model for biomolecular interactions. @_DimensionCap has co-led the founding round alongside Thrive & OpenAI - DIMENSION repostedwe are all underrating the second & third order effects of biologic design costs going to ~$0 congratulations to the chai team!Today we are announcing our collaboration with Pfizer to put Chai's frontier AI—including our latest model, Chai-3—directly into the hands of one of the world's leading pharmaceutical teams.
00:00 - DIMENSION repostedIt's been amazing to watch @joshim5, @jackdent, and team work at speed. This is the wrong time to be a goalpost mover or a chronic under-estimator of ML velocity, and my team at @_DimensionCap would agree. Chai is speed-running what I thought would take years and years. I'mToday we are announcing our collaboration with Pfizer to put Chai's frontier AI—including our latest model, Chai-3—directly into the hands of one of the world's leading pharmaceutical teams.00:00
- DIMENSION reposted
Today we are announcing our collaboration with Pfizer to put Chai's frontier AI—including our latest model, Chai-3—directly into the hands of one of the world's leading pharmaceutical teams.00:00 - DIMENSION reposted
New Limit just raised $435 million. This is, in part, because they've had a massive breakthrough on reversing the age of the liver with their new brand of genetic reprogramming drugs. For the first time, NewLimit's co-founder and president Jacob Kimmel details the company's
00:00 - DIMENSION reposted📣 New @_DimensionCap essay on training data recipes for bio-focused ML models, by @bauer_lesavage The data market is pretty vibrant right now. Frontier labs are buying big chunks of targeted data, multi-modal data, even bio-data. Bio platform companies are benefitting from
- DIMENSION repostedgreat to see GLUE (@MonteRosaTx) get a very well deserved call out today as they pioneer in designing drugs that have potential to help millions of lives across onc and i&i whilst unlocking new classes of mechanisms and modalities
Dimension has co-led a $100M financing into @MonteRosaTx. Thrilled to support @markus_warmuth and the entire team at the cutting edges of geometric deep learning, next gen proteomics, and molecular glue degraders. - DIMENSION reposted
it’s a bad day to be an aging cellalmost exactly 3 years ago Dimension led a $40M Series A in @newlimit, inspired by the pioneering vision of @jacobkimmel @byersblake and @brian_armstrong. today, we announce a $435M Series C led by Founders Fund w Thrive and Greenoaks as new partners. lets go chart the future.
- DIMENSION repostedI love supporting cool and meaningful science, especially when it's being driven by a team with infinite ambition. @newlimit is just that!Following breakthrough results, we’re bringing longevity medicine to human trials. We’ve raised a $435M Series C led by @foundersfund to make it happen. Reprogramming cell age has the potential to create more healthy years for everyone. We're closer than ever to realizing it.
00:00
